Larimar Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Larimar Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- LRMR
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001374690
Board of directors
-
Carole Ben-Maimon · Director · President and CEOSince 2023
-
Frank E. Thomas · DirectorSince 2023
-
James E. Flynn · DirectorSince 2023
-
Jeffrey W. Sherman · DirectorSince 2023
-
Jonathan S. Leff · DirectorSince 2023
-
Joseph Truitt · DirectorSince 2023
-
Thomas Edward Hamilton · DirectorSince 2023
Chief executives
Carole Ben-Maimon
· President and CEO
Dates unknown
Board connections
5 of this board's directors also sit on 4 other boards.
- via James E. Flynn and Jonathan S. Leff
- via Thomas Edward Hamilton
- via Frank E. Thomas
- via Jeffrey W. Sherman
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 22, 2025 | Shankar Gopi Officer (Chief Development Officer) | Grant or award | +23,306 | — | — |
| Jan 22, 2025 | Clayton Russell Officer (Chief Medical Officer) | Grant or award | +23,306 | — | — |
| Jan 22, 2025 | Carole Ben-Maimon Director, Officer (President and CEO) | Grant or award | +91,000 | — | — |
| Jan 22, 2025 | Celano Michael Officer (Chief Financial Officer) | Grant or award | +34,185 | — | — |
| Feb 16, 2024 | Deerfield Mgmt L.P. Director, 10% owner, * Director by Deputization | Open-market purchase | +1,430,206 | $8.74 | $12,500,000 |
| Feb 16, 2024 | Thomas Edward Hamilton Director | Open-market purchase | +57,208 | $8.74 | $499,998 |
| Feb 16, 2024 | Deerfield Mgmt L.P. Director, 10% owner, * Director by Deputization | Open-market purchase | +1,430,206 | $8.74 | $12,500,000 |
| Feb 16, 2024 | Deerfield Mgmt L.P. Director, 10% owner, * Director by Deputization | Open-market purchase | +1,430,205 | $8.74 | $12,499,992 |
| Feb 14, 2024 | Frank E. Thomas Director | Open-market purchase | +2,000 | $11.00 | $22,000 |
| Jan 17, 2024 | Shankar Gopi Officer (Chief Development Officer) | Grant or award | +22,500 | — | — |
| Jan 17, 2024 | Celano Michael Officer (Chief Financial Officer) | Grant or award | +31,250 | — | — |
| Jan 17, 2024 | Clayton Russell Officer (Chief Medical Officer) | Grant or award | +22,500 | — | — |
| Jan 17, 2024 | Carole Ben-Maimon Director, Officer (President and CEO) | Grant or award | +66,125 | — | — |
| Dec 7, 2023 | Shankar Gopi Officer (Chief Development Officer) | Open-market purchase | +5,000 | $3.73 | $18,650 |
| May 17, 2023 | Celano Michael Officer (Chief Financial Officer) | Open-market purchase | +5,000 | $3.73 | $18,650 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.